{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:25:28Z","timestamp":1772331928464,"version":"3.50.1"},"reference-count":45,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Nucl Med Mol Imaging"],"DOI":"10.62347\/gikk5707","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:51:46Z","timestamp":1715136706000},"page":"149-156","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the latest advances in 18F-FDG PET\/CT and cardiac magnetic resonance for imaging for cardiac sarcoidosis diagnosis"],"prefix":"10.62347","volume":"14","author":[{"given":"Seyedeh Nooshin","family":"Miratashi Yazdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11886-019-1238-1","article-title":"Cardiac sarcoidosis","volume":"21","author":"Mankad","year":"2019","unstructured":"Mankad P, Mitchell B, Birnie D and Kron J. Cardiac sarcoidosis. Curr Cardiol Rep 2019; 21: 152.","journal-title":"Curr Cardiol Rep"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","article-title":"Cardiac sarcoidosis","volume":"123","author":"Tan","year":"2019","unstructured":"Tan JL, Fong HK, Birati EY and Han Y. Cardiac sarcoidosis. Am J Cardiol 2019; 123: 513-522.","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.31083\/j.rcm.2020.03.102","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"21","author":"Markatis","year":"2020","unstructured":"Markatis E, Afthinos A, Antonakis E and Papanikolaou IC. Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med 2020; 21: 321-338.","journal-title":"Rev Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jacasi.2021.09.005","article-title":"Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings","volume":"1","author":"Kusano","year":"2021","unstructured":"Kusano K, Ishibashi K, Noda T, Nakajima K, Nakasuka K, Terasaki S, Hattori Y, Nagayama T, Mori K, Takaya Y, Miyamoto K, Nagase S, Aiba T, Yasuda S, Kitakaze M, Kamakura S, Yazaki Y, Morimoto SI, Isobe M and Terasaki F. Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings. JACC Asia 2021; 1: 385-395.","journal-title":"JACC Asia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12149-019-01431-z","article-title":"Diagnosis of cardiac sarcoidosis: an era of paradigm shift","volume":"34","author":"Sharma","year":"2020","unstructured":"Sharma A, Okada DR, Yacoub H, Chrispin J and Bokhari S. Diagnosis of cardiac sarcoidosis: an era of paradigm shift. Ann Nucl Med 2020; 34: 87-93.","journal-title":"Ann Nucl Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2967\/jnumed.119.228130","article-title":"Advanced imaging in cardiac sarcoidosis","volume":"60","author":"Ramirez","year":"2019","unstructured":"Ramirez R, Trivieri M, Fayad ZA, Ahmadi A, Narula J and Argulian E. Advanced imaging in cardiac sarcoidosis. J Nucl Med 2019; 60: 892-898.","journal-title":"J Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.13104\/imri.2019.23.2.100","article-title":"Recent update of advanced imaging for diagnosis of cardiac sarcoidosis: based on the findings of cardiac magnetic resonance imaging and positron emission tomography","volume":"23","author":"Chang","year":"2019","unstructured":"Chang S, Lee WW and Chun EJ. Recent update of advanced imaging for diagnosis of cardiac sarcoidosis: based on the findings of cardiac magnetic resonance imaging and positron emission tomography. Investig Magn Reson Imaging 2019; 23: 100-113.","journal-title":"Investig Magn Reson Imaging"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1032444","DOI":"10.3389\/fnume.2022.1032444","article-title":"Recent advances in PET-MRI for cardiac sarcoidosis","volume":"2","author":"Munoz","year":"2022","unstructured":"Munoz C, Schneider A, Botnar RM and Prieto C. Recent advances in PET-MRI for cardiac sarcoidosis. Front Nucl Med 2022; 2: 1032444.","journal-title":"Front Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/heartjnl-2019-316442","article-title":"Cardiac sarcoidosis: state-of-the-art review","volume":"107","author":"Kouranos","year":"2021","unstructured":"Kouranos V and Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart 2021; 107: 1591-1599.","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tcm.2022.04.007","article-title":"Update on cardiac sarcoidosis","volume":"33","author":"Tan","year":"2023","unstructured":"Tan JL, Tan BE, Cheung JW, Ortman M and Lee JZ. Update on cardiac sarcoidosis. Trends Cardiovasc Med 2023; 33: 442-455.","journal-title":"Trends Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.14797\/mdcvj.1057","article-title":"Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis","volume":"18","author":"Mathai","year":"2022","unstructured":"Mathai SV, Patel S, Jorde UP and Rochlani Y. Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis. Methodist Debakey Cardiovasc J 2022; 18: 78-93.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"788502","DOI":"10.3389\/fimmu.2021.788502","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang","year":"2021","unstructured":"Zhang H, Costabel U and Dai H. The role of diverse immune cells in sarcoidosis. Front Immunol 2021; 12: 788502.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","unstructured":"Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI and Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J 2023; 44: 1495-1510.","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/hearts2020019","article-title":"Cardiac sarcoidosis: pathophysiology, diagnosis, and management","volume":"2","author":"Pour-Ghaz","year":"2021","unstructured":"Pour-Ghaz I, Kayali S, Abutineh I, Patel J, Roman S, Nayyar M and Yedlapati N. Cardiac sarcoidosis: pathophysiology, diagnosis, and management. Hearts 2021; 2: 234-250.","journal-title":"Hearts"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","unstructured":"Ungprasert P, Ryu JH and Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin Proc Innov Qual Outcomes 2019; 3: 358-375.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref15","unstructured":"Blankstein R and Stewart GC. Clinical manifestations and diagnosis of cardiac sarcoidosis. UpToDate 2018."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Weng W, Wiefels C, Chakrabarti S, Nery PB, Celiker-Guler E, Healey JS, Hruczkowski TW, Quinn FR, Promislow S, Medor MC, Spence S, Odabashian R, Alqarawi W, Juneau D, de Kemp R, Leung E, Beanlands R and Birnie D. Atrial arrhythmias in clinically manifest cardiac sarcoidosis: incidence, burden, predictors, and outcomes. J Am Heart Assoc 2020; 9: e017086.","DOI":"10.1161\/JAHA.120.017086"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/jcm10091941","article-title":"Clinical features and diagnosis of cardiac sarcoidosis","volume":"10","author":"Tana","year":"2021","unstructured":"Tana C, Mantini C, Donatiello I, Mucci L, Tana M, Ricci F, Cipollone F and Giamberardino MA. Clinical features and diagnosis of cardiac sarcoidosis. J Clin Med 2021; 10: 1941.","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr&#xF6","year":"2019","unstructured":"Ekström K, Lehtonen J, Nordenswan HK, Mäyränpää MI, Räisänen-Sokolowski A, Kandolin R, Simonen P, Pietilä-Effati P, Alatalo A, Utriainen S, Rissanen TT, Haataja P, Kokkonen J, Vihinen T, Miettinen H, Kaikkonen K, Kerola T and Kupari M. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J 2019; 40: 3121-3128.","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1513\/AnnalsATS.201902-119CME","article-title":"Update in cardiac sarcoidosis","volume":"16","author":"Ribeiro Neto","year":"2019","unstructured":"Ribeiro Neto ML, Jellis CL, Joyce E, Callahan TD, Hachamovitch R and Culver DA. Update in cardiac sarcoidosis. Ann Am Thorac Soc 2019; 16: 1341-1350.","journal-title":"Ann Am Thorac Soc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11882-022-01046-x","article-title":"Cardiac sarcoidosis: current approaches to diagnosis and management","volume":"22","author":"Rosario","year":"2022","unstructured":"Rosario KF, Brezitski K, Arps K, Milne M, Doss J and Karra R. Cardiac sarcoidosis: current approaches to diagnosis and management. Curr Allergy Asthma Rep 2022; 22: 171-182.","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref21","unstructured":"Kolluri N, Schmidt TJ, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Schirger JA, Rosenbaum AN and Cooper LT. Routine laboratory biomarkers as prognostic indicators of cardiac sarcoidosis outcomes. Sarcoidosis Vasc Diffuse Lung Dis 2022; 39: e2022023."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1007\/s12350-021-02655-1","article-title":"Right ventricular involvement of cardiac sarcoidosis: a comprehensive evaluation using cardiovascular magnetic resonance imaging and positron emission tomography","volume":"29","author":"Aikawa","year":"2022","unstructured":"Aikawa T, Ibe T, Manabe O and Oyama-Manabe N. Right ventricular involvement of cardiac sarcoidosis: a comprehensive evaluation using cardiovascular magnetic resonance imaging and positron emission tomography. J Nucl Cardiol 2022; 29: 3593-3595.","journal-title":"J Nucl Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10741-020-10035-z","article-title":"The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis","volume":"26","author":"Tadic","year":"2021","unstructured":"Tadic M, Cuspidi C, Saeed S, Milojevic B and Milojevic IG. The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis. Heart Fail Rev 2021; 26: 653-660.","journal-title":"Heart Fail Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"100503","DOI":"10.1016\/j.ejro.2023.100503","article-title":"Gadolinium contrast agents-challenges and opportunities of a multidisciplinary approach: literature review","volume":"11","author":"Iyad","year":"2023","unstructured":"Iyad N, S Ahmad M, Alkhatib SG and Hjouj M. Gadolinium contrast agents-challenges and opportunities of a multidisciplinary approach: literature review. Eur J Radiol Open 2023; 11: 100503.","journal-title":"Eur J Radiol Open"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jmir.2019.09.006","article-title":"Advances in contrast agents for contrast-enhanced magnetic resonance imaging","volume":"50","author":"Khairnar","year":"2019","unstructured":"Khairnar S, More N, Mounika C and Kapusetti G. Advances in contrast agents for contrast-enhanced magnetic resonance imaging. J Med Imaging Radiat Sci 2019; 50: 575-589.","journal-title":"J Med Imaging Radiat Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1007\/s00330-020-06765-1","article-title":"Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis","volume":"30","author":"Flam&#xE9","year":"2020","unstructured":"Flamée L, Symons R, Degtiarova G, Dresselaers T, Gheysens O, Wuyts W, Van Cleemput J and Bogaert J. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Eur Radiol 2020; 30: 3702-3710.","journal-title":"Eur Radiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s12350-021-02757-w","article-title":"Cardiac sarcoidosis: advantages and limitations of advanced cardiac imaging","volume":"29","author":"Bokhari","year":"2022","unstructured":"Bokhari S and Sheikh T. Cardiac sarcoidosis: advantages and limitations of advanced cardiac imaging. J Nucl Cardiol 2022; 29: 2145-2148.","journal-title":"J Nucl Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"7457369","DOI":"10.1155\/2018\/7457369","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis","volume":"2018","author":"Zhang","year":"2018","unstructured":"Zhang J, Li Y, Xu Q, Xu B and Wang H. Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis. Can Respir J 2018; 2018: 7457369.","journal-title":"Can Respir J"},{"key":"ref29","unstructured":"Bahrami M, Mohammadi H, Mirgaloyebayat H, Mohajeri Z, Fazeli P, Mojahedi A, Afsharirad A, Tavakoli R, Sadeghian A and Nourian SMA. The role of 18F-fluorodeoxyglucose PET\/computed tomography in the diagnosis and monitoring of large vessel vasculitides-a review article. Am J Nucl Med Mol Imaging 2023; 13: 127-135."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J and Dwivedi G. The utility of whole body 18F-FDG PET-CT in diagnosing isolated cardiac sarcoidosis: the Western Australian Cardiac Sarcoid Study. Heart Lung Circ 2020; 29: e1-e6.","DOI":"10.1016\/j.hlc.2019.07.007"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/ph14121286","article-title":"PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers","volume":"14","author":"Saric","year":"2021","unstructured":"Saric P, Young KA, Rodriguez-Porcel M and Chareonthaitawee P. PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers. Pharmaceuticals (Basel) 2021; 14: 1286.","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Wiefels C, Lamai O, Kandolin R, Birnie D, Leung E, Mesquita CT and Beanlands R. The role of 18 F-FDG PET\/CT in cardiac sarcoidosis. Int J Cardiovasc Sci 2020; 33: 389-400.","DOI":"10.36660\/ijcs.20200033"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jcmg.2019.01.011","article-title":"Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis","volume":"12","author":"Alvi","year":"2019","unstructured":"Alvi RM, Young BD, Shahab Z, Pan H, Winkler J, Herzog E and Miller EJ. Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis. JACC Cardiovasc Imaging 2019; 12: 1284-1287.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis","volume":"27","author":"SJ","year":"2020","unstructured":"Kim SJ, Pak K and Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J Nucl Cardiol 2020; 27: 2103-2115.","journal-title":"J Nucl Cardiol"},{"key":"ref35","unstructured":"Al Hayja MA and Vinjamuri S. Cardiac sarcoidosis: the role of cardiac MRI and 18F-FDG-PET\/CT in the diagnosis and treatment follow-up. Br J Cardiol 2023; 30: 7."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","unstructured":"Cheung E, Ahmad S, Aitken M, Chan R, Iwanochko RM, Balter M, Metser U, Veit-Haibach P, Billia F, Moayedi Y, Ross HJ and Hanneman K. Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging 2021; 5: 24.","journal-title":"Eur J Hybrid Imaging"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"134","author":"Gowani","year":"2020","unstructured":"Gowani Z, Habibi M, Okada DR, Smith J, Derakhshan A, Zimmerman SL, Misra S, Gilotra NA, Berger RD, Calkins H, Tandri H and Chrispin J. Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis. Am J Cardiol 2020; 134: 123-129.","journal-title":"Am J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","article-title":"Diagnostic utility of fusion 18 F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis","volume":"29","author":"Okune","year":"2022","unstructured":"Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T, Hanaoka K, Kaida H, Ishii K, Nakazawa G, Miyazaki S and Iwanaga Y. Diagnostic utility of fusion 18 F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol 2022; 29: 753-764.","journal-title":"J Nucl Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13550-021-00870-y","article-title":"The usefulness of repeated CMR and FDG PET\/CT in the diagnosis of patients with initial possible cardiac sarcoidosis","volume":"11","author":"Mathijssen","year":"2021","unstructured":"Mathijssen H, Tjoeng TWH, Keijsers RGM, Bakker ALM, Akdim F, van Es HW, van Beek FT, Veltkamp MV, Grutters JC and Post MC. The usefulness of repeated CMR and FDG PET\/CT in the diagnosis of patients with initial possible cardiac sarcoidosis. EJNMMI Res 2021; 11: 129.","journal-title":"EJNMMI Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jcmg.2021.08.018","article-title":"Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis","volume":"15","author":"Greulich","year":"2022","unstructured":"Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C and Krumm P. Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis. JACC Cardiovasc Imaging 2022; 15: 445-456.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10554-020-02090-2","article-title":"Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study","volume":"37","author":"Kebed","year":"2021","unstructured":"Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R and Patel AR. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. Int J Cardiovasc Imaging 2021; 37: 1361-1369.","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","unstructured":"Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B and Prato FS. Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis. J Nucl Cardiol 2020; 27: 2118-2129.","journal-title":"J Nucl Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12410-022-09571-z","article-title":"Imaging in cardiac sarcoidosis: complementary role of cardiac magnetic resonance and cardiac positron emission tomography","volume":"15","author":"JA","year":"2022","unstructured":"Slivnick JA, Wali E and Patel AR. Imaging in cardiac sarcoidosis: complementary role of cardiac magnetic resonance and cardiac positron emission tomography. Curr Cardiovasc Imaging Rep 2022; 15: 79-88.","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"785279","DOI":"10.3389\/fcvm.2021.785279","article-title":"Current state and future directions of multimodality imaging in cardiac sarcoidosis","volume":"8","author":"Wand","year":"2022","unstructured":"Wand AL, Chrispin J, Saad E, Mukherjee M, Hays AG and Gilotra NA. Current state and future directions of multimodality imaging in cardiac sarcoidosis. Front Cardiovasc Med 2022; 8: 785279.","journal-title":"Front Cardiovasc Med"}],"container-title":["American Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajnmmi\/14\/2\/ajnmmi0155751.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:53:07Z","timestamp":1766022787000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajnmmi\/14\/2\/ajnmmi0155751.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/gikk5707","relation":{},"ISSN":["2160-8407"],"issn-type":[{"value":"2160-8407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}